 Yes, I have an advantage in one way because I've taken care of patients, oncology patients. I'm a medical oncologist and a cancer geneticist. So I kind of have a setting in which I know we need to translate the discoveries into. And we're seeing great hope for some of the immunotherapeutics that we're showing some promise in the clinic and some of the chemotherapies we have.